دورية أكاديمية
Phase I Dose-Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy in Patients With Human Epidermal Growth Factor Receptor 2--Overexpressing Breast Cancer.
| العنوان: | Phase I Dose-Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy in Patients With Human Epidermal Growth Factor Receptor 2--Overexpressing Breast Cancer. |
|---|---|
| المؤلفون: | A. Jo Chien, Munster, Pamela N., Melisko, Michelle E., Rugo, Hope S., Park, John W., Goga, Andrei, Auerback, Glenna, Khanafshar, Elham, Ordovas, Karen, Koch, Kevin M., Moasser, Mark M. |
| المصدر: | Journal of Clinical Oncology; 5/10/2014, Vol. 32 Issue 14, p1472-1479, 8p |
| قاعدة البيانات: | Supplemental Index |
كن أول من يترك تعليقا!